Central and renal hemodynamic effects of a new agonist at peripheral dopamine- and beta-2 adrenoreceptors (dopexamine) in patients with heart failure (original) (raw)

Role of the beta2 adrenoceptor in mediating positive inotropic activity in the failing heart and its relation to the hemodynamic actions of dopexamine hydrochloride

Kenneth Borow

The American Journal of Cardiology, 1988

View PDFchevron_right

Effects of dopaminergic agents on cardiac and renal function in normal man and in patients with congestive heart failure

Kong Lie

International Journal of Cardiology, 1992

View PDFchevron_right

Haemodynamic response to dopexamine hydrochloride in postinfarction heart failure: lack of tolerance after continuous infusion

Leif Erhardt

Heart, 1988

View PDFchevron_right

Use of dopexamine hydrochloride in intensive care patients with low-output left ventricular heart failure

F. Colardyn

The American Journal of Cardiology, 1988

View PDFchevron_right

Evaluation of dopexamine hydrochloride as an anti-hypertensive agent after cardiac surgery

Gavin Kenny

International Journal of Clinical Monitoring and Computing, 1991

View PDFchevron_right

Renal hemodynamic effects of dopexamine hydrochloride

Richard Foulds

The American Journal of Cardiology, 1988

View PDFchevron_right

Human renovascular effects of dopexamine hydrochloride: A novel agonist of peripheral dopamine and beta2-adreno-receptors

Richard Foulds

European Journal of Clinical Pharmacology, 1987

View PDFchevron_right

Relative significance of dopamine receptors, beta adrenoceptors and norepinephrine uptake inhibition in the cardiovascular actions of dopexamine hydrochloride

Leonard Goldberg

The American Journal of Cardiology, 1988

View PDFchevron_right

Hemodynamic effect of dobutamine in patients with severe heart failure

Nasim Akhtar

American Journal of Cardiology, 1975

View PDFchevron_right

Effect of dopexamine hydrochloride on renal vascular resistance index and haemodynamic responses following coronary artery bypass graft surgery

Steve Bolsin

European Journal of Anaesthesiology, 1997

View PDFchevron_right

Impact of Dopamine Infusion on Renal Function in Hospitalized Heart Failure Patients: Results of the Dopamine in Acute Decompensated Heart Failure (DAD-HF) Trial

Gregory Giamouzis, Charalambos Parisis

Journal of Cardiac Failure, 2010

View PDFchevron_right

Cardiovascular pharmacology of dopexamine in low output congestive heart failure

Philip Binkley

The American Journal of Cardiology, 1988

View PDFchevron_right

Renal effect of dopexamine hydrochloride in patients with chronic renal dysfunction

Tarek Eldiasty

Urological Research, 1992

View PDFchevron_right

Effects of dopamine on left ventricular afterload and contractile state in heart failure: Relation to the activation of beta1-adrenoceptors and dopamine receptors

Kenneth Borow

Journal of The American College of Cardiology, 1988

View PDFchevron_right

Dobutamine in chronic ischemic heart failure: Alterations in left ventricular function and coronary hemodynamics

Thomas Ports

The American Journal of Cardiology, 1981

View PDFchevron_right

Short- and long-term dobutamine treatment in chronic ischemic heart failure

Nili Zafrir

Clinical Cardiology, 1987

View PDFchevron_right

Cardiovascular effects of dobutamine in severe congestive heart failure

Joseph Andy

American Heart Journal, 1977

View PDFchevron_right

Haemodynamic response during low-dose dobutamine infusion in patients with chronic systolic heart failure: Comparison of echocardiographic and invasive measurements

Christian Tuxen

2013

View PDFchevron_right

Comparative hemodynamic effects of intravenous dobutamine and MDL-17,043, a new cardioactive drug, in severe congestive heart failure

m Iacona

American Heart Journal, 1985

View PDFchevron_right

Hemodynamic and Renal Effects of Dopexamine and Dobutamine in Patients With Reduced Cardiac Output Following Coronary Artery Bypass Grafting

Roger Royster

Chest, 1994

View PDFchevron_right

The effects of dopexamine hydrochloride on cardiopulmonary haemodynamics following cardiopulmonary bypass surgery

Yugan Mudaliar

International Journal of Cardiology, 1989

View PDFchevron_right

Low dose dopamine in prevention of GFR deterioration in acute decompensated heart failure with preserved ejection fraction

Ahmed Bendary

Journal of Cardiovascular Disease Research (JCDR), 2021

View PDFchevron_right

Selective dopamine-1 receptor agonist augments regional myocardial blood flow: comparison of fenoldopam and dopamine

Andrew Maroko

American Heart …, 1992

View PDFchevron_right

Renal synthesis of dopamine in asymptomatic post-infarction left ventricular systolic dysfunction

Patricio Soares-da-Silva

Clinical Science, 2000

View PDFchevron_right

Additive effects of dobutamine and amrinone on myocardial contractility and ventricular performance in patients with severe heart failure

Joseph Gage

Circulation, 1986

View PDFchevron_right

Dopamine-induced changes in renal blood flow in normals and in patients with renal dysfunction

Juraj Madaric

Catheterization and Cardiovascular Interventions, 2008

View PDFchevron_right

Hemodynamics and renal function during administration of low-dose dopamine in severely ill patients

José Luiz Gomes do Amaral

Sao Paulo Medical Journal, 2004

View PDFchevron_right

Effects of prolonged infusion of dopexamine on β 1 - and β 2 -adrenoceptors in guinea-pig myocardium

Roger Summers

Journal of Autonomic Pharmacology, 1990

View PDFchevron_right

The prescribing pattern of dopamine and dobutamine in congestive heart failure patients in a tertiary care teaching hospital

World Journal of Pharmaceutical Sciences

View PDFchevron_right

The hemodynamic and metabolic advantages gained by a three-day infusion of dobutamine in patients with congestive cardiomyopathy

R. Altschuld

American Heart Journal, 1983

View PDFchevron_right

Influence of dobutamine and dopamine on hemodynamics and plasma concentrations of noradrenaline and renin in patients with low cardiac output following acute myocardial infarction

Ursula Gundert-remy

European Journal of Clinical Pharmacology, 1980

View PDFchevron_right

COMPARISON OF THE VASODILATOR ACTION OF DOPAMINE AND DOPAMINE AGONISTS IN THE RENAL AND CORONARY BEDS OF THE DOG

Owen Woodman

British Journal of Pharmacology, 1982

View PDFchevron_right

Effects of dobutamine on left ventricular performance and myocardial metabolic demands in patients with ischemic heart disease

M. Vandormael

Clinical Cardiology, 1984

View PDFchevron_right

Changes in regional blood flow distribution induced by infusions of dopexamine hydrochloride or dobutamine in anesthetized dogs

George Biro

The American Journal of Cardiology, 1988

View PDFchevron_right

The renal effect of low-dose dopamine in high-risk patients undergoing coronary angiography

Morris Mosseri

Journal of the American College of Cardiology, 1999

View PDFchevron_right